Nouvelle déclaration d'incident
No de la demande: 2023-0770
Numéro de référence du titulaire d'homologation: 2022-CA-000437
Nom du titulaire (nom légal complet, aucune abbréviation): Wellmark International
Adresse: 100 Stone Road West, Suite 111
Ville: Guelph
État: Ontario
Pays: Canada
Code postal /Zip: N1G 5L3
Incident chez un animal domestique
Pays: CANADA
État: NOVA SCOTIA
Inconnu
ARLA No d'homologation 26413 ARLA No de la demande d'homologation EPA No d'homologation.
Nom du produit: Zodiac Double Action Flea and Tick Shampoo for Cats and Dogs
Oui
Inconnu
Site: Animal / Usage sur un animal domestique
Inconnu
Propriétaire de l'animal
Cat / Chat
Domestic Mediumhair cat
1
Femme
5
4.1
kg
Cutanée
Unknown / Inconnu
Unknown / Inconnu
Système
Unknown / Inconnu
Oui
Oui
2
Day(s) / Jour(s)
Unknown/Inconnu
Treatment / Traitement
(p.ex. description des symptômes tels que la fréquence et la gravité
On 08 Oct 2022, the animal owner bathed the cat with the product as per labelled instructions. At an unknown time following product use, the cat developed foaming at the mouth pupil dilation, shaking, trembling, abnormal gait (abnormally striking paws against the floor), and ataxia. On 12Oct2022, the cat was brought to a veterinary clinic where the cat was bathed, and further unspecified treatments administered. On 14Oct2022, the cat's clinical signs had improved but trembling persisted. On 14 Oct 2022, the cat was discharged from the animal hospital. No further information is expected.
Modérée
Assessment: This product has a wide margin of safety. Mild dermal irritation is possible following topical use. If ingested, mild self-limiting GI irritation may occur which can include foaming at the mouth. Neurological involvement is not expected. Other causes exposure to higher concentration pyrethroid products intended for use on dogs as well as underlying disease remain in strong consideration. Further information including veterinary evaluation, treatments, and response to treatments may have enabled further assessment of causality; however, this information was not provided by the reporter. The information contained in this report is based on self-reported statements provided to the registrant during telephone interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and cannot form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the telephone interviews.